What is Sofgen Pharmaceuticals?
Sofgen Pharmaceuticals is a prominent US-based Contract Development and Manufacturing Organization (CDMO) with over two decades of expertise in pioneering softgel technologies. The company offers comprehensive, end-to-end solutions encompassing development through to final delivery for products within the pharmaceutical, over-the-counter (OTC), and nutraceutical sectors. Adhering strictly to cGMP manufacturing standards, Sofgen Pharmaceuticals has garnered significant certifications, including NSF/ANSI and Health Canada licenses, reinforcing its commitment to quality and regulatory compliance. Their services are tailored for companies in the pharmaceutical and dietary supplement industries seeking superior softgel product manufacturing.
How much funding has Sofgen Pharmaceuticals raised?
Sofgen Pharmaceuticals has raised a total of $138K across 1 funding round:
Debt
$138K
Debt (2021): $138K with participation from PPP
What's next for Sofgen Pharmaceuticals?
The substantial late-stage funding context indicates Sofgen Pharmaceuticals is poised for significant expansion, likely focusing on scaling its manufacturing capabilities, enhancing its technological offerings, or broadening its market reach. This strategic investment will enable the company to further solidify its leadership in the CDMO space, potentially through acquisitions, R&D acceleration, or expanding its operational footprint to meet growing demand for high-quality softgel solutions.
See full Sofgen Pharmaceuticals company page
